Walgreens Company Corporate Profile

Walgreens Company Corporate Profile

The Walgreens logo, a rated credit tenant in 1031Gateway's 1031 Exchange Investing Articles


S&P Rated: Investment Grade BBB (Long-Term)
A-2 (Short-Term)

Current Annual Revenue (WBA):
 $103.44 billion
Current Gross Profit (WBA): 
$26.92 billion
Current Annual Net Income (WBA): $4.22 billion
2015 Fiscal Yr. Revenue Growth (WBA): 34.41%

The Walgreen Company (NYSE & NASDAQ: WBA) is the largest drug retailer in America. Walgreens employs approximately 248,000 people and operates 8,678 stores throughout the 50 states, Washington DC, Puerto Rico, and Guam. Walgreens’ products include over-the-counter medicine and consumer products, pharmacy services, and photo services. Walgreens has expanded through a series of strategic acquisitions. In March of 2011, Walgreens acquired Drugstore.com and Beauty.com. Two years later, Beauty.com was named by Internet Retailer Magazine in its Top 100 online retail sites list. In July 2012, Walgreens paid $6.7 billion for a 45% stake in Alliance Boots and acquired a drug store chain that included USA Drug, Super D Drug, May’s Drug, Med-X and Drug Warehouse. Walgreens also maintains a commercial book of pharmacy business through multiyear agreements with Express Scripts, Caremark, and other commercial payers. Walgreens was included in Fortune’s World’s Most Admired Companies list for the 20th consecutive year, and was ranked 37th overall in revenue on the Fortune 500 list of largest U.S.-based companies. Walgreens is actively pursuing innovative growth strategies involving cloud-based mobile phone and tablet-accessible services. In 2014 Walgreens purchased the remaining 55% stake in Switzerland- based Alliance Boots that it did not already own. A new holding company was created that now trades as WBA on the NYSE and NASDAQ exchanges in lieu of the previous WAG ticker. In October 2015 WBA announced its impending acquisition of rival Rite Aid for $17.2 billion.

Access 1031 Exchange PropertiesName *PhoneEmailRoleGoalEquity